Why D2 blockade alone falls short in schizophrenia, and what neurotransmitter, genetic and neuroimaging research means for treatment-resistant patients.
|Poll|January 2, 2019
Mini Quiz: Antipsychotics in Women
Author(s)Mary V. Seeman, MDCM, DSc
In some cases, treatment with antipsychotics can pose risks in women. Take the quiz and learn more.
Advertisement
Psychiatrists should advocate for their patients to ensure prompt and state-of-the-art care when they are ill.
Risks for which of the following are increased in women because they take antipsychotics?
Risks for which of the following are increased in women because they take antipsychotics?
Advertisement
Related to this article
New automated connectomics maps synapses across circuits, revealing how inhibitory neuron subtypes shape decision-making and may explain circuit dysfunction in psychiatric disorders.
Explore evolving ethical challenges of long-acting injectable antipsychotics, weighing relapse prevention against coercion, stigma, incentives, and racial equity in clinical practice.
Antipsychotic levels clarify adherence, guide dose escalation up to a point of futility, and offer more than pharmacogenetic testing, says Jonathan Meyer, MD.
Advertisement
Advertisement
Trending on Psychiatric Times
1
The Ozempic Dilemma: Promises and Pitfalls in Psychiatry
2
Schizophrenia: A Telltale of the Brain’s Complexity
3
Talking With Titans: Sheldon Preskorn, MD, on the Evolution of Psychopharmacology
4
Podcast: Interventional Psychiatry and the Challenge of Difficult-to-Treat Depression
5